Goldman Sachs believes that Biohaven offers investors an under-the-radar opportunity to invest in a potentially best-in-class ...

Michael Yee, global head of biotech research at UBS, joins CNBC’s ‘Squawk on the Street’ to explain Moderna's narrower-than-expected loss, why healthcare is outperforming, and vaccine mandates and ...

Eric Schmidt's family office, Hillspire, made 15 investments in 2025, most of them in artificial intelligence, claiming the top spot on CNBC's list.

SACRAMENTO, Calif., Feb. 13, 2026 /PRNewswire/ -- Lunai Bioworks (NASDAQ: LNAI), an AI-powered biotech and biodefense company, was featured on CNBC's Business Minute. Company CEO David Weinstein ...

Shares of biotech company CSL plunged after the company announced that Chief Executive Officer Paul McKenzie will step down.

Pharmaceutical (PJP), (XPH), (PPH) and biotechnology stocks (XBI), (BBH) have officially returned to favor on Wall Street, according to Michael Yee, global head of biotechnology equity research at UBS ...

Jared Holz, Mizuho, joins 'Power Lunch' to talk how to play healthcare and biotech moving into 2026. Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more ...

John Flavin , Portal Innovations CEO, joins 'Fast Money' to discuss if there is still room to run in the biotech space. Got a confidential news tip? We want to hear from you. Sign up for free ...